< Back to previous page
Researcher
Kristl Claeys
- Disciplines:Neurosciences, Biological and physiological psychology, Cognitive science and intelligent systems, Developmental psychology and ageing
Affiliations
- Laboratory for Muscle Diseases and Neuropathies (Lab)
Responsible
From1 Dec 2016 → Today - Laboratory for Muscle Diseases and Neuropathies (Lab)
Member
From1 Dec 2016 → Today - Research Group Experimental Neurology (Division)
Member
From1 Jan 2016 → 30 Nov 2016
Projects
1 - 6 of 6
- Engelstalig: precision medicine en care in patients neuromuscular dystrophyFrom7 Nov 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Evaluating novel radiological and clinical outcome measures in hereditary neuromuscular diseases.From1 Jun 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Mass spectrometry-based autoantibody tests for specific diagnosis of autoimmune diseasesFrom1 Oct 2020 → 30 Sep 2022Funding: IOF - technology validation in lab
- TOWARDS TRIAL READINESS IN HEREDITARY NEUROMUSCULAR DISEASES: Developing accurate, feasible and non-invasive outcome measures.From1 Oct 2019 → 1 Oct 2023Funding: FWO fellowships
- Immune profiling of neurological diseases (IPoN)From1 Aug 2018 → 1 Oct 2023Funding: FWO fellowships
- A comprehensive study of genetic determinants of motor neuron vulnerabilityFrom1 Oct 2017 → 2 May 2022Funding: FWO fellowships
Publications
1 - 10 of 171
- Editorial: Implementing new technologies for neuromuscular disorders(2024)
Authors: Kristl Claeys
- Analysis of muscle magnetic resonance imaging of a large cohort of patient with VCP-mediated disease reveals characteristic features useful for diagnosis(2023)
Authors: Kristl Claeys
Pages: 5849 - 5865 - Identify genetic modifiers controlling severity of collagen-6 related dystrophies (COL6-RD)(2023)
Authors: Kristl Claeys
Pages: S158 - S158 - Effect size analysis of cipaglucosidase alfa plus miglustat versus alglucosidase alfa in ERT-experienced adults with late-onset Pompe disease in PROPEL(2023)
Authors: Kristl Claeys
Pages: S151 - S151 - Histopathological features and autophagy aspects of Ku plus myositis(2023)
Authors: Kristl Claeys
Pages: S94 - S94 - Switching treatment to cipaglucosidase alfa plus miglustat positively affects motor function and quality of life in patients with late-onset Pompe disease(2023)
Authors: Kristl Claeys
Pages: S151 - S151 - Refining MRI pattern in sarcoglycanopathies: upper body pattern and new approaches to assess disease progression(2023)
Authors: Kristl Claeys
Pages: S77 - S77 - 104-week efficacy and safety of cipaglucosidase alfa plus miglustat in patients with late-onset Pompe disease previously treated with alglucosidase alfa(2023)
Authors: Kristl Claeys
Pages: S191 - S191 - Muscle biopsy findings in a large cohort of patients affected by valosin containing protein disease: preliminary analysis of the international multicentric VCP study(2023)
Authors: Kristl Claeys
Pages: S138 - S139 - IgG-derived peptides and other biomarkers for CIDP(2023)
Authors: Joris Godelaine, Koen Poesen, Xavier Bossuyt, Kristl Claeys